Analyst Recommendations

Morgan Stanley analyst issues OVERWEIGHT recommendation for SE on March 13, 2026 11:15AM ET. The previous analyst recommendation was Overweight.SE was trading at $85.16 at issue of the...

March 13, 2026   SE 5.48%

Morgan Stanley analyst issues POSITIVE recommendation for SEAT on March 13, 2026 11:15AM ET. The previous analyst recommendation was Positive.SEAT was trading at $5.65 at issue of the...

March 13, 2026   SEAT -0.09%

Benchmark analyst issues BUY recommendation for OMCL on March 13, 2026 11:14AM ET. The previous analyst recommendation was Buy.OMCL was trading at $35.1 at issue of the analyst...

March 13, 2026   OMCL 2.60%

UBS analyst issues BUY recommendation for OMCL on March 13, 2026 11:14AM ET. The previous analyst recommendation was Buy.OMCL was trading at $35.1 at issue of the analyst...

March 13, 2026   OMCL 2.60%

Guggenheim analyst issues BUY recommendation for RBRK on March 13, 2026 11:29AM ET. The previous analyst recommendation was Buy.RBRK was trading at $54.02 at issue of the analyst...

March 13, 2026   RBRK 7.44%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for KRRO on March 13, 2026 11:27AM ET. The previous analyst recommendation was Overweight.KRRO was trading at $11.5 at issue of the...

March 13, 2026   KRRO 9.91%

Scotiabank analyst issues SECTOR PERFORM recommendation for S on March 13, 2026 11:27AM ET. The previous analyst recommendation was Sector Perform.S was trading at $13.78 at issue of...

March 13, 2026   S 2.10%

Scotiabank analyst issues SECTOR OUTPERFORM recommendation for SLG on March 13, 2026 11:27AM ET. The previous analyst recommendation was Sector Outperform.SLG was trading at $37.88 at issue of...

March 13, 2026   SLG 3.01%

Cantor Fitzgerald analyst issues NEUTRAL recommendation for HCAT on March 13, 2026 11:24AM ET. The previous analyst recommendation was Neutral.HCAT was trading at $1.79 at issue of the...

March 13, 2026   HCAT 5.93%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for CRVS on March 13, 2026 11:23AM ET. The previous analyst recommendation was Overweight.CRVS was trading at $16.01 at issue of the...

March 13, 2026   CRVS 8.88%